UnknownNot Applicable

Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting

Belgium300 participantsStarted 2012-02

Plain-language summary

This is a prospective specimen collection study targeting patients presenting with Influenza Like Illness (ILI) and/or Acute Respiratory Infection (ARI) in an out-patient setting. A non-invasive, user friendly sampling technique, using midturbinate flocked swabs will be used. These nasal swabs will be collected in different volumes of viral transport media (0.5mL and 3.0mL), for different dilution range of the viruses present in the collected biological specimen. The collection of nasal swabs samples will support the optimization of point of care detection methods for respiratory viruses responsible for ILI and/or ARI.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or Female * All Ages * Valid Informed Consent and/or Assent, where applicable * Onset of ILI and/or ARI within the last 3 days (≤ 72h) * Patient presented with ILI and/or ARI Exclusion Criteria: * Invalid Informed Consent and/or Assent * Onset of ILI and/or ARI was \> 3 days (\> 72 h) * Patient did not presented with neither ILI or ARI * Patient received intranasal attenuated influenza virus in last 3 weeks (example FluMist®, Fluenz®) * Patient received treatment with influenza direct antivirals in the last 7 days

What they're measuring

Nasal swab collection of left and right nostril

Timeframe: 1 day

Trial details

NCT IDNCT01687816

SponsorLieselot Houspie

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Influenza-like Illness trials